Literature DB >> 19503669

The role of positron emission tomography in the management of non-small cell lung cancer.

Abdollah Behzadi1, Yee Ung, Val Lowe, Claude Deschamps.   

Abstract

The potential use of positron emission tomography (PET) imaging in patients with non-small cell lung cancer (NSCLC) is broadly divided into 5 categories: management of solitary pulmonary nodule, mediastinal lymph node evaluation, detection of metastases, evaluation of response to chemoradiation and detection of recurrence. The purpose of this review is to discuss the current clinical applications of (18)F-fluorodeoxyglucose PET in patients with NSCLC and to discuss future applications and developments of this technology.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19503669      PMCID： PMC2689740     

Source DB:  PubMed          Journal:  Can J Surg        ISSN： 0008-428X            Impact factor:   2.089


  79 in total

Review 1.  Seeking a home for a PET, part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses.

Authors:  Frank C Detterbeck; Steven Falen; M Patricia Rivera; Jan S Halle; Mark A Socinski
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

2.  Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.

Authors:  Dirk Hellwig; Andreas Gröschel; Thomas P Graeter; Anne P Hellwig; Ursula Nestle; Hans-Joachim Schäfers; Gerhard W Sybrecht; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-09       Impact factor: 9.236

3.  Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; S G Stroobants; P J Dupont; P R De Leyn; E K Verbeken; G J Deneffe; L A Mortelmans; M G Demedts
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

Authors:  Ping Yang; Mark S Allen; Marie C Aubry; Jason A Wampfler; Randolph S Marks; Eric S Edell; Stephen Thibodeau; Alex A Adjei; James Jett; Claude Deschamps
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

5.  Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.

Authors:  N Lorent; P De Leyn; Y Lievens; E Verbeken; K Nackaerts; C Dooms; D Van Raemdonck; B Anrys; J Vansteenkiste
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

6.  Diabetes Decreases FDG Accumulation in Primary Lung Cancer.

Authors:  Tatsuo Torizuka; Kenneth R. Zasadny; Richard L. Wahl
Journal:  Clin Positron Imaging       Date:  1999-10

7.  Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Authors:  Robert J Downey; Timothy Akhurst; Mithat Gonen; Alain Vincent; Manjit S Bains; Steven Larson; Valerie Rusch
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

8.  Non-small cell lung carcinoma adrenal metastases. Computed tomography and percutaneous needle biopsy in their diagnosis.

Authors:  J J Pagani
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 10.  18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.

Authors:  Yee C Ung; Donna E Maziak; Jessica A Vanderveen; Christopher A Smith; Karen Gulenchyn; Christina Lacchetti; William K Evans
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506
View more
  12 in total

1.  Clinical stage of lung cancer revised by accidental pneumothorax and positron emission tomography.

Authors:  Qingliang Xue; Junping Sun; Lina Guo; Jianxin Wang
Journal:  Med Oncol       Date:  2010-04-06       Impact factor: 3.064

2.  PET-CT in the staging and treatment of non-small-cell lung cancer.

Authors:  Patricia Ibeas; Blanca Cantos; José Manuel Gasent; Begoña Rodríguez; Mariano Provencio
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

3.  Combination of radiological and gray level co-occurrence matrix textural features used to distinguish solitary pulmonary nodules by computed tomography.

Authors:  Haifeng Wu; Tao Sun; Jingjing Wang; Xia Li; Wei Wang; Da Huo; Pingxin Lv; Wen He; Keyang Wang; Xiuhua Guo
Journal:  J Digit Imaging       Date:  2013-08       Impact factor: 4.056

Review 4.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

5.  Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging.

Authors:  Hatsuho Mamata; Junichi Tokuda; Ritu R Gill; Robert F Padera; Robert E Lenkinski; David J Sugarbaker; James P Butler; Hiroto Hatabu
Journal:  Magn Reson Med       Date:  2012-01-09       Impact factor: 4.668

Review 6.  18F-FDG PET/CT imaging in oncology.

Authors:  Ahmad Almuhaideb; Nikolaos Papathanasiou; Jamshed Bomanji
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

Review 7.  PET/CT imaging in lung cancer: indications and findings.

Authors:  Bruno Hochhegger; Giordano Rafael Tronco Alves; Klaus Loureiro Irion; Carlos Cezar Fritscher; Leandro Genehr Fritscher; Natália Henz Concatto; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

8.  Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India.

Authors:  Sushma Agrawal
Journal:  South Asian J Cancer       Date:  2013-10

9.  Diagnostic value of 18F-FDG-PET/CT in benign lung diseases.

Authors:  Ayse Gul Ergonul; Tevfik Ilker Akcam; Ali Özdil; Kutsal Turhan; Alpaslan Cakan; Ufuk Cagirici
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-03-28

10.  In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT.

Authors:  Natasa Matic; Marcus Ressner; Emilia Wiechec; Karin Roberg
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.